Skye Bioscience, Inc. Professional Fees
Skye Bioscience, Inc. (SKYE) reported Professional Fees of $2.70 thousand for the 3-month period ending 2014-07-31, per its 10-Q filed 2014-09-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2014-09-15
- Skye Bioscience, Inc. professional fees for the quarter ending 2014-07-31 was $2.70K, a 65.98% decline year-over-year.
- Skye Bioscience, Inc. professional fees for the quarter ending 2014-04-30 was $17.32K, a 311.35% increase year-over-year.
- Skye Bioscience, Inc. professional fees for the quarter ending 2014-01-31 was $2.98K, a 60.53% decline year-over-year.
- Skye Bioscience, Inc. professional fees for the quarter ending 2013-10-31 was $12.16K, a 1759.02% increase year-over-year.
- Skye Bioscience, Inc. professional fees for fiscal 2013 was $32.16K, a 2571.43% increase from fiscal 2012.
- Skye Bioscience, Inc. professional fees for fiscal 2012 was $1.20K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month | Professional Fees 25 month | Professional Fees 29 month |
|---|---|---|---|---|---|---|
| 2014-07-31 | $2.70K 10-Q · filed 2014-09-15 | $20.02K derived: sum of 2 quarters · filed 2014-09-15 | $22.99K 10-Q · filed 2014-09-15 | $35.15K derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2014-04-30 | $17.32K 10-Q · filed 2014-06-05 | $20.29K 10-Q · filed 2014-06-05 | $32.45K derived: sum of 3 quarters · filed 2014-06-05 | $40.39K derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2014-01-31 | $2.98K 10-Q · filed 2014-03-17 | $15.13K derived: sum of 2 quarters · filed 2014-03-17 | $23.07K derived: sum of 3 quarters · filed 2014-09-15 | $27.28K derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2013-10-31 | $12.16K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $20.09K derived: sum of 2 quarters · filed 2014-09-15 | $24.30K derived: sum of 3 quarters · filed 2014-09-15 | $32.16K 10-K · filed 2014-01-27 | ||
| 2013-07-31 | $7.94K 10-Q · filed 2014-09-15 | $12.15K derived: sum of 2 quarters · filed 2014-09-15 | $20.01K 10-Q · filed 2014-09-15 | $20.34K derived: sum of 4 quarters · filed 2014-09-15 | $22.98K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $4.21K 10-Q · filed 2014-06-05 | $11.75K 10-Q · filed 2014-06-05 | $12.40K derived: sum of 3 quarters · filed 2014-06-05 | $12.40K derived: sum of 4 quarters · filed 2014-06-05 | $15.04K 10-Q · filed 2013-06-27 | |
| 2013-01-31 | $7.54K 10-Q · filed 2014-03-17 | $8.19K derived: sum of 2 quarters · filed 2014-03-17 | $8.19K derived: sum of 3 quarters · filed 2014-03-17 | $8.74K derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-10-31 | $654.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $654.00 derived: sum of 2 quarters · filed 2014-01-27 | $1.20K derived: sum of 3 quarters · filed 2014-01-27 | $1.20K 10-K · filed 2014-01-27 | ||
| 2012-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-16 | $550.00 derived: sum of 2 quarters · filed 2013-09-16 | $550.00 10-Q · filed 2013-09-16 | |||
| 2012-04-30 | $550.00 10-Q · filed 2013-06-27 | $550.00 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |